| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/18/1996 | WO1996011214A1 Peptides and pharmaceutical compositions comprising them |
| 04/18/1996 | WO1996011208A1 Radioactive phosphorous labeling of proteins for targeted radiotherapy |
| 04/18/1996 | WO1996011020A1 Rheumatoid arthritis remedy containing il-6 antagonist as active ingredient |
| 04/18/1996 | WO1996011019A1 Interleukin-12 as an adjuvant for paramyxoviridae vaccines |
| 04/18/1996 | WO1996011013A1 Cdr-grafted type iii anti-cea humanized mouse monoclonal antibodies |
| 04/18/1996 | WO1996010997A1 Hepatitis virus vaccines |
| 04/18/1996 | WO1996007739A3 Interleukin-1 type 3 receptors |
| 04/18/1996 | DE4436558A1 Prepn. of vaccine against allergy inducing cpds. |
| 04/18/1996 | DE4436352A1 Verfahren zur diagnostischen Beurteilung und Verlaufskontrolle sowie Arzneimittel zur Therapie von Schockzuständen beim Menschen Method for the diagnostic assessment and monitoring and drugs for the treatment of shock in humans |
| 04/18/1996 | DE19507166C1 Antibodies specific for fusion polypeptide(s) contg. a histidine component |
| 04/18/1996 | CA2202088A1 Hepatitis virus vaccines |
| 04/18/1996 | CA2202029A1 Methods for producing enhanced antigenic helicobacter sp. and vaccines comprising same |
| 04/18/1996 | CA2202027A1 Methods for producing enhanced antigenic enteric bacteria and vaccines comprising same |
| 04/18/1996 | CA2201935A1 Peptides and pharmaceutical compositions comprising them |
| 04/18/1996 | CA2201592A1 Enhanced immune response by introduction of cytokine gene and/or costimulatory molecule b7 gene in a recombinant virus expressing system |
| 04/17/1996 | EP0706799A2 Immunoconjugates II |
| 04/17/1996 | EP0706792A1 Method of potentiating an immune response and compositions therefor |
| 04/17/1996 | EP0706657A1 Inhibiting protein interactions |
| 04/17/1996 | EP0706656A1 Immunoassay for soluble fibrin polymers |
| 04/17/1996 | EP0706574A1 Methods for peptide synthesis and purification |
| 04/17/1996 | EP0706573A1 Protein tyrosine kinase and ligands thereof |
| 04/17/1996 | EP0706571A1 Tuberculosis vaccine |
| 04/17/1996 | EP0706568A1 Vertebrate apoptosis gene: compositions and methods |
| 04/17/1996 | EP0706566A1 Conotoxins having acetylcholin receptor binding properties |
| 04/17/1996 | EP0706400A1 Therapeutic formulation and method |
| 04/17/1996 | EP0651822B1 Diagnostic method |
| 04/17/1996 | EP0618815B1 Monoclonal antibodies against type i phospholipase a 2?, used as a therapeutic agent to reduce inflammation |
| 04/17/1996 | EP0506826B1 Antibody antagonists of human interleukin-4 |
| 04/17/1996 | EP0483194B1 IgG3 ANTIBODIES WITH SHORTENED HINGE REGION AND A COMPLEMENT ACTIVATION TEST |
| 04/17/1996 | EP0429534B1 Molecular conjugates containing cell membrane-blending agents |
| 04/17/1996 | EP0428596B1 Novel infectious bursal disease virus |
| 04/17/1996 | EP0424519B1 Antigenes of the envelope transmembrane glycoprotein of a human retrovirus of the hiv-2 type, and antigens presenting with them an immunological relationship |
| 04/17/1996 | EP0401271B1 Antigen against diabetes |
| 04/17/1996 | EP0290565B1 Vaccine containing tick antigens |
| 04/17/1996 | CN1120854A Rapamycin assay |
| 04/17/1996 | CN1120852A Needleless syringe using supersonic gas flow for particle delivery |
| 04/17/1996 | CN1120809A Immunological response potentiation process |
| 04/16/1996 | US5508386 An immunoglobulin molecule containing a tetrapeptide epitope within the third complementarity-determining region in the n-terminus variable domain thereof |
| 04/16/1996 | US5508186 Has vp1 minor structural protein to vp2 major structural protein ratio higher than the ratio of naturally occurring full capsid |
| 04/16/1996 | US5508167 Detecting presence or absence of an apolipoprotein e type 4 isoform(apoe4) in subject by immunoassay |
| 04/11/1996 | WO1996010641A1 An attenuated vaccination and gene-transfer virus, a method to make the virus and a pharmaceutical composition comprising the virus |
| 04/11/1996 | WO1996010639A2 THE tagA GENE AND METHODS FOR DETECTING PREDISPOSITION TO PEPTIC ULCERATION AND GASTRIC CARCINOMA |
| 04/11/1996 | WO1996010634A1 Inhibitor of stem cell proliferation and uses thereof |
| 04/11/1996 | WO1996010633A1 Chimeric influenza virus and electroporation method |
| 04/11/1996 | WO1996010632A1 Recombinant negative strand rna virus expression systems and vaccines |
| 04/11/1996 | WO1996010631A1 Nucleic acid encoding mutant matrix proteins useful for attenuation or enhancement of influenza a virus |
| 04/11/1996 | WO1996010583A1 Vaccine containing a haemoprotein |
| 04/11/1996 | WO1996010580A2 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 04/11/1996 | WO1996010577A1 Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof |
| 04/11/1996 | WO1996010423A1 COMPOSITIONS CONTAINING A p53 DERIVED PROTEIN OR PEPTIDE, AN ADJUVANT, AND INTERLEUKIN-12 AND USES THEREOF |
| 04/11/1996 | WO1996010421A1 Vaccine compositions |
| 04/11/1996 | WO1996010420A1 Composition and treatment for hyperimmunization with non heat-killed bacteria |
| 04/11/1996 | WO1996010419A2 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
| 04/11/1996 | WO1996010415A1 Preparation of mhc-peptide complexes |
| 04/11/1996 | WO1996010414A1 Trophinin and trophinin-assisting proteins |
| 04/11/1996 | WO1996010413A1 Compositions containing tumor rejection antigen precursors or tumor rejection antigens, and an adjuvant and/or growth factor |
| 04/11/1996 | WO1996010411A1 Immunotherapeutic stress protein-peptide complexes against cancer |
| 04/11/1996 | WO1996010400A1 Gene therapy vectors and vaccines based on non-segmented negatives stranded rna viruses |
| 04/11/1996 | WO1996005866A3 Live vaccine for the treatment of tumour diseases |
| 04/11/1996 | DE4436164A1 New conjugates of tetra:carbohydrate and amide-linked peptide or dye etc. |
| 04/11/1996 | CA2201588A1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 04/11/1996 | CA2201519A1 Preparation of mhc-peptide complexes |
| 04/11/1996 | CA2201498A1 Immunotherapeutic stress protein-peptide complexes against cancer |
| 04/11/1996 | CA2201353A1 The taga gene and methods for detecting predisposition to peptic ulceration and gastric carcinoma |
| 04/11/1996 | CA2201327A1 Compositions containing tumor rejection antigen precursors or tumor rejection antigens, and an adjuvant and/or growth factor |
| 04/11/1996 | CA2201302A1 An attenuated vaccination and gene-transfer virus, a method to make the virus and a pharmaceutical composition comprising the virus |
| 04/11/1996 | CA2201119A1 Trophinin and trophinin-assisting proteins |
| 04/11/1996 | CA2160100A1 Carbohydrate conjugates as inhibitors of cell adhesion |
| 04/10/1996 | EP0705844A1 Gene encoding cationic amino acid transporter protein |
| 04/10/1996 | EP0705435A1 A novel family of pollen proteinases, methods of use thereof and compositions derived therefrom |
| 04/10/1996 | EP0705346A1 Monoclonal antibodies against the alpha pdgf receptor and uses thereof |
| 04/10/1996 | EP0705339A1 Human cell adhesion protein aamp-1 and uses thereof |
| 04/10/1996 | EP0705278A1 Apoptose inhibitor |
| 04/10/1996 | EP0705277A1 Prostaglandin receptor ep3 and dna encoding it |
| 04/10/1996 | EP0705276A1 Prostaglandin receptor fp and dna encoding it |
| 04/10/1996 | EP0705110A1 Immunoglobulin infusion in xenotransplantation |
| 04/10/1996 | EP0705109A1 Adjuvants for vaccines against respiratory syncytial virus |
| 04/10/1996 | EP0705108A1 Cryptic peptides for use in inducing immunologic tolerance |
| 04/10/1996 | EP0705104A1 Method of cancer treatment |
| 04/10/1996 | EP0547079B1 New use of a monoclonal antibody |
| 04/10/1996 | EP0484438B1 Biological preparation and its use |
| 04/10/1996 | EP0387286B1 Monoclonal antibody specific to a novel epitope of the lfa-1 antigen of human t lymphocytes |
| 04/10/1996 | EP0289550B1 Vaccine for use in the therapeutic treatment of hsv |
| 04/10/1996 | CN1120353A Anti-microbial agents and screening method therefor |
| 04/10/1996 | CN1120315A 35/31 KDA subunit of the entamoeba histolytica adherence lectin |
| 04/10/1996 | CN1120310A Polymeric mucoadhesives in the delivery of immunogens at mucosal surfaces |
| 04/09/1996 | US5506343 Antibodies specific for the DF3 carcinoma associated antigen |
| 04/09/1996 | US5506342 Chemical reduction, crosslinking, chelating, cleaving and stabilizing |
| 04/09/1996 | US5506271 Method of treating papilloma virus infection using hypericin |
| 04/09/1996 | US5506139 Vaccines, immunology |
| 04/09/1996 | US5506135 Fab fragment, having specificities against fibrin and thrombolytic substances |
| 04/09/1996 | US5506134 Hypridoma and monoclonal antibody which inhibits blood coagulation tissue factor/factor VIIa complex |
| 04/09/1996 | US5506132 Monoclonal antibodies or binding fragments thereof |
| 04/09/1996 | US5506130 Contacting bottom of container surface with mixture of cells suspended in a media to permit desired cells bound to surface, separating unbound cells, removing bound cells, suspending in second media, repeating the above steps |
| 04/09/1996 | US5506129 Virus production |
| 04/09/1996 | US5506128 Recombinant infectious bovine rhinotracheitis virus |
| 04/09/1996 | US5506119 DNA encoding variant CD44 surface proteins associated with metastatic tumors |
| 04/09/1996 | US5506107 Selecting ligand agonists and antagonists |
| 04/09/1996 | US5505967 Pharmaceutical loaded into alkali insoluble particle in enteric material; for delivery to peyer's glands |
| 04/09/1996 | US5505947 Attenuating mutations in Venezuelan Equine Encephalitis virus |